Aryltricyclospirodienones; novel steroid mimics as inhibitors of aromatase

Journal of the Chemical Society - Perkin Transactions 1

Volumn , Issue 10, 1997, Pages 1511-1516

  Hobbs Mallyon, David ^a   Li, Warren ^a   Whiting, Donald A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748721633     PISSN: 0300922X     EISSN: None     Source Type: Journal    
DOI: 10.1039/a608338b     Document Type: Article

References (53)

1. Cytochrome P-450; Structure, Mechanism and Biochemistry, ed. P. R. Ortiz de Montellano, Plenum Press, 1986, pp. 217-271;
2. M. Akhtar, D. E. Stevenson and J. N. Wright, J. Chem. Soc., Perkin Trans. 1, 1988, 2043;
3. J. Y. Kellis and L. E. Vickery, J. Biol. Chem., 1987, 262, 4413, 8840;
4. M. Ahkhtar and J. N. Wright, Nat. Prod. Rep., 1991, 527;
5. E. R. Simpson, M. S. Mahendroo, G. D. Means, M. W. Kilgore, M. M. Hinshelwood, S. Graham-Lorence, B. Amarneh, Y. Ito, C. R. Fisher, M. D. Michael, C. R. Mendelson and S. E. Bulun, Endocr. Rev., 1994, 15, 342.
6. (a) J. O. Johnston and B. W. Metcalf, Novel Approaches to Cancer Chemotherapy, ed. P. S. Sunkara, Academic Press, 1984, p. 307;
7. A. Manni and R. J. Santen, Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion, Bailliere-Tindall, 1987, p. 255;
8. D. F. Covey, Sterol Biosynthesis Inhibitors: Pharmaceutical and Agrochemical Aspects, ed. D. Berg and M. Plempel, Ellis Horwood, 1988, p. 534;
9. A. M. H. Brodie, Design of Enzyme Inhibitors as Drugs, ed. M. Sander and H. J. Smith, Oxford University Press, 1989, p. 503;
10. (b) Inter alia P. K. Siiteri and E. A. Thompson, J. Steroid. Biochem., 1975, 6, 317;
11. R. W. Bruggemeier, E. E. Floyd and R. E. Councell, J. Med. Chem., 1978, 21, 1007;
12. D. F. Covey, W. F. Hood and V. D. Parikh, J. Biol. Chem., 1981, 256, 1076;
13. B. W. Metcalf, C. L. Wright, J. P. Burkhart and J. O. Johnston, J. Am. Chem. Soc., 1981, 103, 3221;
14. P. A. Marcotte and C. H. Robinson, Biochemistry, 1982, 21, 2773;
15. P. R. Ortiz de Montellano, K. L. Kunze, H. S. Beilan and C. Wheeler, Biochemistry, 1982, 21, 1331;
16. M. G. B. Drew, J. Mann and B. Pietrzak, J. Chem. Soc., Chem. Commun., 1985, 1191;
17. J. N. Wright, M. R. Calder and M. Akhtar, J. Chem. Soc., Chem. Commun., 1985, 1733;
18. L. Tan and A. Petit, Biochem. Biophys. Res. Commun., 1985, 128, 613;
19. M. J. Shih, M. H. Carrell, H. L. Carrell, C. L. Wright, J. O. Johnston and C. H. Robinson, J. Chem. Soc., Chem. Commun., 1987, 213;
20. W. E. Childers and C. H. Robinson, J. Chem. Soc., Chem. Commun., 1987, 320;
21. J. T. Kellis, Jr, W. E. Childers, C. H. Robinson and L. E. Vickery, J. Biol. Chem., 1987, 262, 4421;
22. M. Akhtar, J. N. Wright, P. T. van Leersum and S. G. Chamberlin, J. Chem. Soc., Perkin Trans. 1, 1989, 1647;
23. P. A. Cole and C. H. Robinson, J. Med. Chem., 1990, 33, 2933;
24. J. Am. Chem. Soc., 1991, 113, 8130;
25. R. W. Bruggemeier, Breast Cancer Res. Treat., 1994, 30, 31;
26. H. V. Bossche, H. Moereels and L. M. H. Koymans, Breast Cancer Res. Treat., 1994, 30, 43;
27. J. Geelen, H. J. J. Loozen, G. H. Deckers, R. Deleeuw, H. J. Kloosterboer and S. W. J. Lamberts, J. Steroid Biochem. Mol. Biol., 1993, 44, 681;
28. W. Wouters, E. Snoeck and R. Decoster, Breast Cancer Res. Treat., 1994, 30, 89;
29. P. V. Plourde, M. Dyroff and M. Dukes, Breast Cancer Res. Treat., 1994, 30, 103;
30. A. Lipton, L. M. Demers, H. A. Harvey, K. B. Kambic, H. Grossberg, C. Brady, H. Adlercruetz, P. F. Trunet, R. J. Santen, P. V. Plourde, M. Dyroff and M. Dukes, Cancer, 1995, 75, 2132;
31. N. Oohata, Y. Hori, Y. Yamagishi, T. Fujita, S. Takase, M. Yamashita, H. Terano and M. Okuhara, J. Antibiot., 1995, 48, 757;
32. M. Lourdusamy, F. Labrie and S. M. Singh, Synth. Commun., 1995, 25, 3655;
33. H. I. Holland, S. Kumaresan and G. Lakshmaiah, Can. J. Chem., 1995, 73, 2185;
34. E. J. T. Dasilva, M. L. S. E. Melo and A. S. C. Neves, J. Chem. Soc., Perkin Trans. 1, 1996, 1649;
35. V. C. O. Njar, J. Duerkop and R. W. Hartmann, Steroids, 1996, 61, 138.
36. C. Geynet, C. Millet, H. Truong and E. E. Baulieu, Gynaecol. Invest., 1972, 3, 2;
37. V. C. Jordan and B. Gosden, Mol. Cell. Endrocrinol., 1982, 27, 291.
38. We acknowledge valuable discussions with, and personal communications from, Dr F. T. Boyle, Zeneca Pharmaceuticals, Alderly Park, Macclesfield, UK.
39. D. F. Covey and W. F. Hood, Cancer Res., Suppl., 1982, 42, 3327;
40. G. A. Flynn, J. O. Johnston, C. L. Wright and B. W. Metcalf, Biochem. Biophys. Res. Commun., 1981, 103, 913.
41. Energy minimisations were estimated using MacroModel, version 4.0, with MM2 force field parameters, and employing 'Monte Carlo' global searches; we thank Dr M. Luszniak for these calculations.
42. O. Hares, D. Hobbs-Mallyon and D. A. Whiting, J. Chem. Soc., Perkin Trans. 1, 1993, 1481.
43. N. Campbell and D. Kidd, J. Chem. Soc., 1954, 2154.
44. F. M. Dean and K. B. Hindley, Tetrahedron Lett., 1972, 15, 1445.
45. A. S. Hussey and R. R. Herr, J. Org. Chem., 1959, 24, 843.
46. J. K. Stille and R. A. Newsom, J. Org. Chem., 1961, 26, 1375.
47. A generous gift of this material from Zeneca Pharmaceuticals is acknowledged.
48. -6 M were employed.
49. E. A. Thompson, Jr and P. K. Siiteri, J. Biol. Chem., 1974, 249, 5373;
50. P. E. Graves and H. A. Salhanick, Endocrinology, 1979, 105, 52;
51. C. A. Laughton, R. McKenna, S. Neidle, M. Jarman, R. McCague and M. G. Rowlands, J. Med. Chem., 1990, 33, 2673.
52. T. R. Kasturi and T. Arunachalam, Can. J. Chem., 1968, 46, 3625.
53. D. Lednicer, J. C. Babcock, S. C. Lyster and G. W. Duncan, Chem. Ind., 1963, 408.